Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin- mediated cytotoxicity

Journal of Clinical Investigation

Volumn 99, Issue 11, 1997, Pages 2745-2751

  Spencer, Melissa J ^a   Walsh, Craig M ^a   Dorshkind, Kenneth A ^a   Rodriguez, Encarnacion Montecino ^a   Tidball, James G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cellular immunity; Cytotoxicity; Duchenne muscular dystrophy; In vivo depletion; Lymphocytes

Indexed keywords

DYSTROPHIN; PERFORIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; DUCHENNE MUSCULAR DYSTROPHY; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031010857     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119464     Document Type: Article

References (51)

1. Hoffman, E.P., R.J. Brown, and L.M. Kunkel. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 51:919-928.
2. Partridge, T. 1991. Animal models of muscular dystrophy - what can they teach us? Neuropathol. Appl. Neurobiol. 17:353-363.
3. Hoffman, E.P., and J.R.M. Gorospe. 1991. The animal models of Duchenne muscular dystrophy: windows on the pathophysiological consequences of dystrophin deficiency. In Current Topics in Membranes. M.S. Mooseker, and J.S. Morrow, editors. Academic Press, Inc., Orlando. 113-154.
4. Bulfield, G., W.G. Siller, P.A.L. Wight, and K.J. Moore. 1984. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA. 81:1189-1192.
5. Kunkel, L.M., and E.P. Hoffman. 1989. Duchenne/Becker muscular dystrophy: a short overview of the gene, the protein, and current diagnostics. Br. Med. Bull. 45:630-643.
6. Tidball, J.G., D.E. Albrecht, B.E. Lokensgard, and M.J. Spencer. 1995. Apoptosis precedes necrosis in dystrophin-deficient muscle. J. Cell Sci. 108: 2197-2204.
7. Zychlinsky, A., L.M. Zheng, C.C. Liu, and J.D. Young. 1991. Cytolytic lymphocytes induce both apoptosis and necrosis in target cells. J. Immunol. 146: 393-400.
8. Torres, L.F.B., and L.W. Duchen. 1987. The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain. 110:269-299.
9. Arahata, K., and A.G. Engel. 1988. Monoclonal antibody analysis of mononuclear cells in myopathies. IV. Cell-mediated cytotoxicity and muscle fiber necrosis. Ann. Neurol. 23:168-173.
10. McDouall, R.M., M.J. Dunn, and V. Dubowitz. 1990. Nature of the mononuclear infiltrate and the mechanism of muscle damage in juvenile dermatomyositis and Duchenne muscular dystrophy. J. Neurol. Sci. 99:199-217.
11. Emslie-Smith, A.M., K. Arahata, and A. Engel. 1989. Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and t cell-mediated cytotoxicity in myopathies. Hum. Pathol. 20:224-231.
12. Engel. A.G., and K. Arahata. 1986. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum. Pathol. 17:704-721.
13. Fenichel, G.M., J.M. Florence, A. Pestronk, J.R. Mendell, R.C. Moxley, R.C. Griggs, M.H. Brooke, J.P. Miller, J. Robison, and W. King. 1991. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology. 41:1874-1877.
14. Griggs, R.C., R.C. Moxley, J.R. Mendell, G.M. Fenichel, M.H. Brooke, A. Pestronk, and J.P. Miller. 1991. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch. Neurol. 48:383-388.
15. Drachman, D.B., K.V. Toyka, and E. Myer. 1974. Prednisone in Duchenne muscular dystrophy. Lancet. 2:1409-1412.
16. Brooke, M.H., G.M. Fenichel, R.C. Griggs, J.R. Mendell, R.C. Moxley, J.P. Miller, K.K. Kaiser, J.M. Florence, S. Pandya, and L. Signore. 1987. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. Arch. Neurol. 44:812-817.
17. Kissel, J.T., K.L. Burrow, K.W. Rammohan, and J.R. Mendell. 1991. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group. Neurology. 41: 667-672.
18. Gussoni, E., G.K. Pavlath, R.G. Miller, M.A. Panzara, M. Posell, H.M. Blau, and L. Steinman. 1994. Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J. Immunol. 153:4798-4805.
19. Kagi, D., F. Vignaux, B. Lederman, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxicity. Science (Wash. DC). 265:528-530.
20. Walsh, C.M., M. Matloubian, C.C. Liu, R. Ueda, C.G. Kurahara, J.L. Christensen, M.T. Huang, J.D. Young, R. Ahmed, and W.R. Clark. 1994. Immune function in mice lacking the perform gene. Proc. Natl. Acad. Sci. USA. 91: 10854-10858.
21. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.). 369:31-37.
22. Berke, G. 1995. The CTL's kiss of death. Cell. 81:9-12.
23. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. 298-299.
24. Spencer, M.J., D.E. Croall, and J.G. Tidball. 1995. Calpains are activated in necrotic fibers from mdx mice. J. Biol. Chem. 270:10909-10914.
25. Tidball, J.G., and M.S. Spencer. 1993. PDGF stimulation induces phosphorylation of talin and cytoskeletal reorganization in skeletal muscle. J. Cell Biol. 123:627-635.
26. Spencer, M.J., and J.G. Tidball. 1996. Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. Exp. Cell. Res. 226:264-272.
27. Nuovo, G.J., J. Becker, A. Simsir, M. Margiotta, G. Khalife, and M. Shevchuk. 1994. HIV-I nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. Am. J. Pathol. 144:1142-1148.
28. Spencer, M.J., B. Lu, and J.G. Tidball. 1997. Calpain II expression is increased by changes in mechanical loading of muscle in vivo. J. Cell. Biochem. 64:55-66.
29. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
30. Gonzalez, Q.R., R. Baccala, R.M. Pope, and A.N. Theofilopoulos. 1996. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J. Clin. Invest. 97:1335-1343.
31. Utz, U., and H.F. McFarland. 1994. The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor. J. Neuropathol. Exp. Neurol. 53:351-358.
32. Mullis, K., F. Faloona, S. Scharf, R. Saiki, G. Horn, and H. Erlich. 1992. Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Biotechnology. 24:17-27.
33. Arahata, K., and A.G. Engel. 1984. Monoclonal antibody analysis of mononuclear cells in myopathies I. Ann. Neurol. 16:193-208.
34. Arahata, K., and A.G. Engel. 1986. Monoclonal antibody analysis of mononuclear cells in myopathies III. Ann. Neurol. 19:112-125.
35. Mokri, B., and A. Engel. 1975. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology. 25:1111-1120.
36. Engel, A.G., and K. Arahata. 1984. Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann. Neurol. 16:209-215.
37. Nagata, S. 1994. Apoptosis regulated by a death factor and its receptor: Fas ligand and Fas. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345:281-287.
38. Kennedy, M.K., K.S. Picha, W.C. Fanslow, K.H. Grabstein, M.R. Alderson, K.N. Clifford, W.A. Chin, and K.M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 2:370-378.
39. McDonald, S.W., and J. Halliday. 1992. Cell-mediated immune response after vasectomy in rats. J. Reprod. Fertil. 96:529-535.
40. Eichbaum, Q.G., D.W. Beatty, and M.I. Parker. 1994. Identification of cardiac autoantigens in human heart cDNA libraries using acute rheumatic fever sera. J. Autoimm. 7:243-261.
41. Maisch, B. 1989. Autoreactivity to the cardiac myocyte, connective tissue and the extracellular matrix in heart disease and postcardiac injury. Springer Semin. Immunopathol. 11:369-395.
42. Latif, N., C.S. Baker, M.J. Dunn, M.L. Rose, P. Brady, and M.H. Yacoub. 1993. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J. Am. Coll. Cardiol. 22:1378-1384.
43. Neu, N., C. Pummerer, T. Rieker, and P. Berger. 1993. T cells in cardiac myosin-induced myocarditis. Clin. Immunol. Immunopathol. 68:107-110.
44. Pasternak, C., S. Wong, and E.L. Elson. 1995. Mechanical function of dystrophin in muscle cells. J. Cell Biol. 128:355-361.
45. Turner, P.R., P.Y. Fong, W.F. Denetclaw, and R.A. Steinhardt. 1991. Increased calcium influx in dystrophic muscle. J. Cell Biol. 115:1701-1712.
46. Mc Ardle, A., and M.J. Jackson. 1996. Heat shock protein 70 expression in skeletal muscle. Biochem. Soc. Trans. 24:485S.
47. Flanagan, S.W., A.J. Ryan, C.V. Gisolfi, and P.L. Moseley. 1995. Tissue-specific HSP70 response in animals undergoing heat stress. Am. J. Physiol. 268: R28-R32.
48. Puntschart, A., M. Vogt, H.R. Widmer, H. Hoppeler, and R. Billeter. 1996. Hsp70 expression in human skeletal muscle after exercise. Acta Physiol. Scand. 157:411-417.
49. Jegadeesh Babu, G., R. Prabhakar, C.C. Kartha, and C. Rajamanickam. 1994. Expression of proto-oncogenes, genes for muscle specific isoforms and heat shock protein (HSP)-70 gene in hypertrophied cardiac muscles from patients with atrial septal defect or tetralogy of Fallot. Biochem. Mol. Biol. Int. 34: 627-637.
50. Watt, D.J., J.E. Morgan, and T.A. Partridge. 1984. Long term survival of allografted muscle precursor cells following a limited period of treatment with cyclosporin A. Clin. Exp. Immunol. 55:419-426.
51. Morgan, J.E., and T.A. Partridge. 1992. Cell transplantation and gene therapy in muscular dystrophy. Bioessays. 14:641-645.